gswith
Login
gswith
Home
Questions
Articles
Guidance
Login
GSWITH
  • Questions
  • Help

Policy
  • Privacy Policy
  • Question Policy
  • Answer Policy

Company
  • About
  • Terms of Services
  • Contact Us

© amITsoft Core Private Limited 2023

nilotinib

nilotinib
mpp
sub-licence
1
answer
0
votes

Which companies have signed sub-licence agreements to produce generic versions of Nilotinib for chronic myeloid leukaemia

Four manufacturers have signed sub-licence agreements with MPP to produce generic versions of Niloti
newspaper

New to Gswith

Register for an account to unlock personalized profiles, exclusive content, and the opportunity to connect with like-minded individuals.

Sign up
Site Stats
36
Users
50,874
Q&A
1,407,094
Page Views
6,668
Topics
Trending Topics
economy governance security judiciary conservation federalism democracy defence biodiversity public-trust
More
gswith Logo
The Knowledge Hub for Aspiring Civil Servants5
GSWITH
  • Questions
  • Help
Policy
  • Privacy Policy
  • Question Policy
  • Answer Policy
Company
  • About
  • Terms of Services
  • Contact Us

© amITsoft Core Private Limited 2023

gswith
Home
Questions
Articles
Guidance
Login
GSWITH
  • Questions
  • Help

Policy
  • Privacy Policy
  • Question Policy
  • Answer Policy

Company
  • About
  • Terms of Services
  • Contact Us

© amITsoft Core Private Limited 2023

Alert